Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Tobacco Dependence Treatment in the ED
NCT02896400Phase 3Completed
- Sponsor
- Yale University
- Start
- Feb 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by Yale University. Started Feb 2017; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02896400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02896400.